1 |
Venkateshiah SB, Yan TD, Bonfield TL, Thomassen MJ, Meziane M, Czich C, et al. An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest 2006;130:227-37
DOI
ScienceOn
|
2 |
Kitamura T, Tanaka N, Watanabe J, Uchida, Kanegasaki S, Yamada Y, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999;190:875-80
DOI
ScienceOn
|
3 |
Nam SB, Park KY, Lee HJ, Jung JW, Choi YH, Kim HS, et al. A case of pulmonary alveolar proteinosis with spontaneous resolution. Tuberc Respir Dis 2007;63: 294-8
DOI
ScienceOn
|
4 |
Golde DW, Territo M, Finley TN, Cline MJ. Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 1976;85:304-9
DOI
PUBMED
ScienceOn
|
5 |
Shibata Y, Berclaz PY, Chroneos ZC, Yoshida M, Whitsett JA, Trapnell BC. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity 2001;15:557-67
DOI
ScienceOn
|
6 |
Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med 2003;349:2527-39
DOI
PUBMED
ScienceOn
|
7 |
Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK. Exogenous granulocyte-macrophage colony stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000;161:1143-8
DOI
PUBMED
|
8 |
Bonfield TL, Raychaudhuri B, Malur A, Abraham S, Trapnell BC, Kavuru MS, et al. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte- macrophage colony-stimulating factor. Am J Physiol Lung Cell Mol Physiol 2003;285:L1132-6
DOI
PUBMED
|
9 |
Kim G, Lee SJ, Lee HP, Yoo CG, Han SK, Shim YS, et al. The clinical characteristics of pulmonary alveolar proteinosis: experience at Seoul National University Hospital, and review of the literature. J Korean Med Sci 1999;14:159-64
PUBMED
ScienceOn
|
10 |
Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle IR, et al. Therapeutic efficacy of granulocyte- macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001;163:524-31
DOI
PUBMED
ScienceOn
|
11 |
Robb L, Drinkwater CC, Metcalf D, Li R, Kontgen F, Nicola NA. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colonystimulating factor and interleukins 3 and 5. Proc Natl Acad Sci U S A 1995;92:9565-9
DOI
ScienceOn
|
12 |
Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JA, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci U S A 1994;91: 5592-6
DOI
PUBMED
|